Medicine

NHS England to fund first ever treatment for children with rare muscle-wasting condition

NHS England will provide a promising new treatment which can prolong the lives of children with a rare genetic condition after negotiating a deal with the manufacturer. Nusinersen, also called Spinraza and made by Biogen, is the first treatment that targets the underlying cause of spinal muscular atrophy (SMA). The condition affects the nerves in […]

Read more

NHS England strikes deal to make innovative Multiple Sclerosis drug available, paving the way for NICE recommendation

Patients with Multiple Sclerosis (MS) will have routine access to a drug that can slow disability under a deal struck between NHS England and the manufacturer Roche, paving the way for its approval by NICE. Ocrelizumab (also known as Ocrevus) is the first treatment that can modify or change the course of the disease to […]

Read more

PrEP Impact Trial to be expanded

New places for the PrEP Impact Trial will now start to be released following agreement at the PrEP Oversight Board. Implementation of the PrEP Impact trial has been a huge success with over 11,500 participants already enrolled in this important HIV prevention measure. With the speed of recruitment and need for PrEP significantly exceeding initial […]

Read more

Update on the PrEP Impact Trial

Implementation of the PrEP Impact trial has been a huge success with over 10,000 participants already enrolled in this important HIV prevention measure. But, the speed of recruitment and demand for PrEP has significantly exceeded initial expert predictions and the trial researchers now consider that more places should be made available. They argue that recruitment […]

Read more

First children with cancer to begin treatment with revolutionary CAR-T therapy

The first children to receive a game-changing personalised therapy for cancer will start treatment at Great Ormond Street Hospital in London this week. A second centre, Royal Manchester Children’s Hospital, is also ready to start treating children with a rare form of leukaemia while a third, Newcastle upon Tyne Hospitals NHS Foundation Trust, is expected […]

Read more